Single ascending dose + mulitple ascending dose study of PQ912

• Research type

  Research Study

• Full title

  A Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PQ912 in Healthy Male and Female Subjects

• IRAS ID

  126634

• Contact name

  Joseph Chiesa

• Contact email

  Joseph.Chiesa@Covance.com

• Sponsor organisation

  Probiodrug AG

• Eudract number

  2013-000849-39

• ISRCTN Number

  N/A

• REC name

  North East - York Research Ethics Committee

• REC reference

  13/NE/0111

• Date of REC Opinion

  19 Apr 2013

• REC opinion

  Favourable Opinion